ORIOLA Share Price Performance
€0.99
-0.13 (-11.61%)
21.8% undervalued intrinsic discount
€1.27
Fair Value
Price €0.99
AnalystConsensusTarget €1.27
Fair Value€1.27
Share Pricen/a
Oriola Oyj Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
ORIOLA Community Narratives
AN
Fair Value €1.27 21.8% undervalued intrinsic discount
Nordic Healthcare Demand And ERP Program Will Drive Stronger Long Term Earnings
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
Nordic Healthcare Demand And ERP Program Will Drive Stronger Long Term Earnings
Catalysts About Oriola Oyj Oriola Oyj is a Nordic healthcare and pharmaceutical distribution company that ensures the efficient flow of medicines and health products to pharmacies, hospitals and other care providers. What are the underlying business or industry changes driving this perspective?Read more
4
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
AN
€1.27
21.8% undervalued intrinsic discount
Fair Value
Profit Margin
1.1%
Future PE
12.46x
Price in 2028
€1.49
Trending Discussion
Recently Updated Narratives
AN
Nordic Healthcare Demand And ERP Program Will Drive Stronger Long Term Earnings
Fair Value: €1.27 21.8% undervalued intrinsic discount
3 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Oriola Oyj Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 29, 2026
- -0.15
- 8.78%
- -1.43%
- 58.1%
About ORIOLA
- Founded
- 1907
- Employees
- 869
- CEO
- WebsiteView website
Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services. Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies. The company was founded in 1907 and is headquartered in Espoo, Finland.
